United States · FDA National Drug Code directory
AcetaZOLAMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9006_6468455a-a638-4ef0-8bce-41afa7f24c66
- Product NDC
- 0143-9006
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Acetazolamide
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19960501
- Source listing expiry
- 20261231
Source-listed ingredients
- ACETAZOLAMIDE SODIUM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0143-9006-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL · 0143-9006-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →